Press Release
Category Added in a WPeMatico Campaign
-
Nauto Available as Order Now Partner on Geotab Marketplace, Expanding Access to Predictive AI-Powered Fleet Safety Technology
Predictive, AI-powered safety technology proven to reduce risky driving and help prevent collisions is now available directly through the Geotab…
Read More » -
Halcyon Partners with HYCU to Expand Ransomware Protection to Cloud Environments and Create the First Ransomware-Resilient Data Protection Solution
AUSTIN, Texas, March 31, 2026 /PRNewswire/ — Halcyon, the leading anti-ransomware platform purpose-built to defeat ransomware, today announced a strategic partnership…
Read More » -
SILICOM’S FIRST QUARTER 2026 RESULTS RELEASE SCHEDULED FOR APRIL 30, 2026
– Conference Call Scheduled for Thursday, April 30, 2026 at 9:00am ET – KFAR SAVA, Israel, March 31, 2026 /PRNewswire/…
Read More » -
Exostar Names Amy Hogan Chief Information Officer
Hogan will serve as Exostar’s first CIO amidst company’s continued explosive growth HERNDON, Va., March 31, 2026 /PRNewswire/ — Exostar,…
Read More » -
Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology
Technology Selectively Shuts Down Cancer Reproducing Cells Patent Covers Splice-Switching Oligonucleotide Platform Designed to Induce Apoptosis of Mast Cells NEW…
Read More » -
ContractorHUB secures strategic investment from industry operators to modernize contracting software
Early-stage, customer-backed round brings experienced contractors onto the cap table to accelerate product development and strengthen industry alignment NASHVILLE, Tenn., March…
Read More » -
Vivantio Secures Strategic Investment from Oakman to Accelerate Global Growth & Product Innovation
BOSTON, March 31, 2026 /PRNewswire/ — Vivantio, a flexible IT service management (ITSM) platform designed for modern service organizations, has…
Read More » -
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology
Pralsetinib induced robust and durable responses with a manageable safety profile, reinforcing the benefits of selective RET inhibitors in treating…
Read More » -
Cetera’s RIA Platform Growth Continues with Acquisition of Matkovic Financial Group
Independent practice specializing in wealth management and tax planning oversees $135 million, represents the latest addition to Cetera’s growing RIA…
Read More »
